1. Home
  2. VALU vs AVXL Comparison

VALU vs AVXL Comparison

Compare VALU & AVXL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • VALU
  • AVXL
  • Stock Information
  • Founded
  • VALU 1931
  • AVXL 2004
  • Country
  • VALU United States
  • AVXL United States
  • Employees
  • VALU N/A
  • AVXL N/A
  • Industry
  • VALU Investment Managers
  • AVXL Biotechnology: Biological Products (No Diagnostic Substances)
  • Sector
  • VALU Finance
  • AVXL Health Care
  • Exchange
  • VALU Nasdaq
  • AVXL Nasdaq
  • Market Cap
  • VALU 530.8M
  • AVXL 484.2M
  • IPO Year
  • VALU N/A
  • AVXL N/A
  • Fundamental
  • Price
  • VALU $54.40
  • AVXL $7.45
  • Analyst Decision
  • VALU
  • AVXL Strong Buy
  • Analyst Count
  • VALU 0
  • AVXL 2
  • Target Price
  • VALU N/A
  • AVXL $43.00
  • AVG Volume (30 Days)
  • VALU 11.3K
  • AVXL 1.6M
  • Earning Date
  • VALU 12-13-2024
  • AVXL 11-25-2024
  • Dividend Yield
  • VALU 2.21%
  • AVXL N/A
  • EPS Growth
  • VALU 8.76
  • AVXL N/A
  • EPS
  • VALU 2.13
  • AVXL N/A
  • Revenue
  • VALU $36,628,000.00
  • AVXL N/A
  • Revenue This Year
  • VALU N/A
  • AVXL N/A
  • Revenue Next Year
  • VALU N/A
  • AVXL N/A
  • P/E Ratio
  • VALU $25.58
  • AVXL N/A
  • Revenue Growth
  • VALU N/A
  • AVXL N/A
  • 52 Week Low
  • VALU $36.00
  • AVXL $3.25
  • 52 Week High
  • VALU $58.45
  • AVXL $10.45
  • Technical
  • Relative Strength Index (RSI)
  • VALU 60.41
  • AVXL 54.68
  • Support Level
  • VALU $49.43
  • AVXL $7.55
  • Resistance Level
  • VALU $57.68
  • AVXL $10.45
  • Average True Range (ATR)
  • VALU 1.97
  • AVXL 0.84
  • MACD
  • VALU 0.32
  • AVXL 0.08
  • Stochastic Oscillator
  • VALU 66.29
  • AVXL 37.77

About VALU Value Line Inc.

Value Line Inc is a U.S based company. It produces investment periodicals based on underlying research and making available copyright data, including ranking system and other information, to third parties under written agreements for use in third-party managed and marketed investment products and for other purposes. The company markets under well-known brands including Value Line, the Value Line logo, The Value Line Investment Survey, Smart Research, Smarter Investing and The Most Trusted Name in Investment Research. Its only operating segment being Publishing.

About AVXL Anavex Life Sciences Corp.

Anavex Life Sciences Corp is a clinical-stage biopharmaceutical company engaged in the development of differentiated therapeutics by applying precision medicine to central nervous system diseases with high unmet need. It analyzes genomic data from clinical studies to identify biomarkers, which are used to select patients that will receive the therapeutic benefit for the treatment of neurodegenerative and neurodevelopmental diseases. Its necessary compound ANAVEX 2-73 is being developed to treat Alzheimer's disease, Parkinson's disease, and potentially other central nervous system diseases, including rare diseases, such as Rett syndrome, a rare severe neurological monogenic disorder. The company's operating segment is into developing novel therapies for the management of CNS diseases.

Share on Social Networks: